Financial incentives improve recognition but not treatment of cardiovascular risk factors in severe mental illness

被引:5
|
作者
Wilson, Carol L. [1 ]
Rhodes, Kirsty M. [2 ]
Payne, Rupert A. [1 ,3 ]
机构
[1] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England
[2] MRC Biostat Unit, Cambridge, England
[3] Univ Bristol, Ctr Acad Primary Care, Sch Social & Community Med, Bristol, Avon, England
来源
PLOS ONE | 2017年 / 12卷 / 06期
基金
英国医学研究理事会;
关键词
PRIMARY-CARE; SCHIZOPHRENIA; PEOPLE;
D O I
10.1371/journal.pone.0179392
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives Severe mental illness (SMI) is associated with premature cardiovascular disease, prompting the UK primary care payment-for-performance system (Quality and Outcomes Framework, QOF) to incentivise annual physical health reviews. This study aimed to assess the QOF's impact on detection and treatment of cardiovascular risk factors in people with SMI. Methods A retrospective open cohort study of UK general practice was conducted between 1996 and 2014, using segmented logistic regression with 2004 and 2011 as break points, reflecting the introduction of relevant QOF incentives in these years. 67239 SMI cases and 359951 randomly-selected unmatched controls were extracted from the Clinical Practice Research Datalink (CPRD). Results There was strong evidence (p <= 0.015) the 2004 QOF indicator (general health) resulted in an immediate increase in recording of elevated cholesterol (odds ratio 1.37 (95% confidence interval 1.24 to 1.51)); obesity (OR 1.21 (1.06 to 1.38)); and hypertension (OR 1.19 (1.04 to 1.38)) in the SMI group compared with the control group, which was sustained in subsequent years. Similar findings were found for diabetes, although the evidence was weaker (p = 0.059; OR 1.21 (0.99 to 1.49)). There was evidence (p<0.001) of a further, but unsustained, increase in recording of elevated cholesterol and obesity in the SMI group following the 2011 QOF indicator (cardiovascular specific). There was no clear evidence that the QOF indicators affected the prescribing of lipid modifying medications or anti-diabetic medications. Conclusion Incentivising general physical health review for SMI improves identification of cardiovascular risk factors, although the additional value of specifically incentivising cardiovascular risk factor assessment is unclear. However, incentives do not affect pharmacological management of these risks.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Risk factors for metabolic and cardiovascular disease in inpatients with severe mental illness
    Lavagnino, Luca
    Gurguis, Christopher
    Lane, Scott
    [J]. PSYCHIATRY RESEARCH, 2021, 304
  • [2] Do financial incentives increase treatment adherence in people with severe mental illness? A systematic review
    Burton, Alexandra
    Marougka, Stamatina
    Priebe, Stefan
    [J]. EPIDEMIOLOGIA E PSICHIATRIA SOCIALE-AN INTERNATIONAL JOURNAL FOR EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2010, 19 (03): : 233 - 242
  • [3] Severe mental illness and risk of cardiovascular disease
    Newcomer, John W.
    Hennekens, Charles H.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (15): : 1794 - 1796
  • [4] Cardiovascular risk factors for people with mental illness
    Davidson, S
    Judd, F
    Jolley, D
    Hocking, B
    Thompson, S
    Hyland, B
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2001, 35 (02): : 196 - 202
  • [5] Adiponectin Is Related to Cardiovascular Risk in Severe Mental Illness Independent of Antipsychotic Treatment
    Reponen, Elina J.
    Tesli, Martin
    Dieset, Ingrid
    Steen, Nils Eiel
    Vedal, Trude S. J.
    Szabo, Attila
    Werner, Maren C. F.
    Lunding, Synve H.
    Johansen, Ingrid T.
    Rodevand, Linn N.
    Andreassen, Ole A.
    Ueland, Thor
    [J]. FRONTIERS IN PSYCHIATRY, 2021, 12
  • [6] Cardiovascular Risk Reduction in Patients With Severe Mental Illness
    Hughes, Suzanne
    Himmelfarb, Cheryl R. Dennison
    [J]. JOURNAL OF CARDIOVASCULAR NURSING, 2011, 26 (05) : 349 - 350
  • [7] Severe mental illness: cardiovascular risk assessment and management
    Polcwiartek, Christoffer
    O'Gallagher, Kevin
    Friedman, Daniel J.
    Correll, Christoph U.
    Solmi, Marco
    Jensen, Svend Eggert
    Nielsen, Rene Ernst
    [J]. EUROPEAN HEART JOURNAL, 2024, 45 (12) : 987 - 997
  • [8] Increased cardiovascular risk in patients with severe mental illness
    Gladigau, E. L.
    Fazio, T. N.
    Hannam, J. P.
    Dawson, L. M.
    Jones, S. G.
    [J]. INTERNAL MEDICINE JOURNAL, 2014, 44 (01) : 65 - 69
  • [9] Cardiovascular risk in patients with severe mental illness in Italy
    Salvi, Virginio
    Aguglia, Andrea
    Barone-Adesi, Francesco
    Bianchi, Davide
    Donfrancesco, Chiara
    Dragogna, Filippo
    Palmieri, Luigi
    Serafini, Gianluca
    Amore, Mario
    Mencacci, Claudio
    [J]. EUROPEAN PSYCHIATRY, 2020, 63 (01)
  • [10] Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness
    Vergara-Rodriguez, Pamela
    Vibhakar, Sonia
    Watts, Jeff
    [J]. PHARMACOLOGY & THERAPEUTICS, 2009, 124 (03) : 269 - 278